aiqbench analysis
This research evaluates Large Language Models as zero-shot estimators for medical survival analysis, demonstrating that frontier models can achieve competitive accuracy against specialized statistical methods like Random Survival Forests on specific cancer types. However, the study highlights critical limitations in generalizability and risk discrimination across different institutions and disease categories, suggesting that while LLMs offer a promising approximation capability, they are not yet reliable for universal clinical deployment without further validation.
Large Language Models are Approximate Survival Estimators
arXiv:2609.38181v1 Announce Type: new Abstract: Survival analysis estimates time-to-event outcomes from patient covariates and is widely used for medical risk assessment. Patients seeking prognostic information after a diagnosis may turn to large language models (LLMs), now readily accessible through consumer applications. However, whether LLMs can provide accurate survival predictions has not been rigorously evaluated. We introduce Survprompt, a framework that converts structured patient covariates into free-text clinical vignettes and prompts pre-trained LLMs to predict survival zero-shot. We benchmark Survprompt against conventional survival models, including random survival forests (RSF), across two multi-institutional pan-cancer cohorts: the publicly available MSK-CHORD cohort and a newly curated cohort from the Providence St. Joseph Health Network constructed using an LLM-based medical abstraction framework. We report censored mean absolute error (cMAE) and concordance index (c-index) and conduct feature ablations to identify variables influencing LLM predictions. Frontier LLMs achieved surprisingly competitive cMAE for individual survival times. For example, GPT-5.6-Sol achieved cMAE within 10% of state-of-the-art RSF models specifically trained for survival prediction for several cancer types and lower cMAE than RSF for prostate cancer in MSK-CHORD. Feature ablations revealed that LLMs prioritized clinical variables similarly to specialized survival models. However, LLMs showed inconsistent accuracy across cancer types and institutions and poorly discriminated between high- and low-risk patients (lower c-index). Zero-shot LLMs can generate surprisingly accurate prognostic estimates without specialized training, but their variable performance across cancer types and institutions remains an important limitation for clinical use.
Abstract:Survival analysis estimates time-to-event outcomes from patient covariates and is widely used for medical risk assessment. Patients seeking prognostic information after a diagnosis may turn to large language models (LLMs), now readily accessible through consumer applications. However, whether LLMs can provide accurate survival predictions has not been rigorously evaluated. We introduce Survprompt, a framework that converts structured patient covariates into free-text clinical vignettes and prompts pre-trained LLMs to predict survival zero-shot. We benchmark Survprompt against conventional survival models, including random survival forests (RSF), across two multi-institutional pan-cancer cohorts: the publicly available MSK-CHORD cohort and a newly curated cohort from the Providence St. Joseph Health Network constructed using an LLM-based medical abstraction framework. We report censored mean absolute error (cMAE) and concordance index (c-index) and conduct feature ablations to identify variables influencing LLM predictions. Frontier LLMs achieved surprisingly competitive cMAE for individual survival times. For example, GPT-5.6-Sol achieved cMAE within 10% of state-of-the-art RSF models specifically trained for survival prediction for several cancer types and lower cMAE than RSF for prostate cancer in MSK-CHORD. Feature ablations revealed that LLMs prioritized clinical variables similarly to specialized survival models. However, LLMs showed inconsistent accuracy across cancer types and institutions and poorly discriminated between high- and low-risk patients (lower c-index). Zero-shot LLMs can generate surprisingly accurate prognostic estimates without specialized training, but their variable performance across cancer types and institutions remains an important limitation for clinical use.
Computation and Language (cs.CL)
arXiv:2609.38181 [cs.CL]
(or arXiv:2609.38181v1 [cs.CL] for this version)
https://doi.org/10.48550/arXiv.2609.38181 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 326 words
Related coverage
Humans Are Not Chinchillas: Revisiting “How Quick and Big Would A Software Intelligence Explosion Be?”
LessWrong · Oct 5, 2026

Frontier AI Risk Report (February–March 2026)
METR · May 19, 2026

Informe de riesgos de la IA de frontera (febrero–marzo de 2026)
METR · May 19, 2026

Frontier Risk Report (February to March 2026)
METR · May 19, 2026